What is the share price of Krishna Institute of Medical Sciences Ltd (KIMS) today?
The share price of KIMS as on 11th March 2026 is ₹675.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Krishna Institute of Medical Sciences Ltd (KIMS) share?
The past returns of Krishna Institute of Medical Sciences Ltd (KIMS) share are- Past 1 week: -4.74%
- Past 1 month: 3.25%
- Past 3 months: 2.69%
- Past 6 months: -11.35%
- Past 1 year: 28.27%
- Past 3 years: 141.13%
- Past 5 years: 238.98%
What are the peers or stocks similar to Krishna Institute of Medical Sciences Ltd (KIMS)?
The peers or stocks similar to Krishna Institute of Medical Sciences Ltd (KIMS) include:What is the market cap of Krishna Institute of Medical Sciences Ltd (KIMS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹27549.57 Cr as of 11th March 2026.What is the 52 week high and low of Krishna Institute of Medical Sciences Ltd (KIMS) share?
The 52-week high of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹798.40 and the 52-week low is ₹507.75.What is the PE and PB ratio of Krishna Institute of Medical Sciences Ltd (KIMS) stock?
The P/E (price-to-earnings) ratio of Krishna Institute of Medical Sciences Ltd (KIMS) is 71.65. The P/B (price-to-book) ratio is 11.39.Which sector does Krishna Institute of Medical Sciences Ltd (KIMS) belong to?
Krishna Institute of Medical Sciences Ltd (KIMS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Krishna Institute of Medical Sciences Ltd (KIMS) shares?
You can directly buy Krishna Institute of Medical Sciences Ltd (KIMS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Krishna Institute of Medical Sciences Ltd
KIMS Share Price
NSE₹675.901.83% (-12.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
KIMS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
KIMS Performance & Key Metrics
KIMS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 91.62 | 11.39 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.89 | 5.82 | 0.58% |
94%
Analysts have suggested that investors can buy this stock
from 16 analysts
Price Upside
Earnings Growth
Rev. Growth
KIMS Company Profile
Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.
APOLLOHOSP
PE Ratio
77.60
77.60
1Y Return
26.89%
26.89%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
94.34
94.34
1Y Return
8.17%
8.17%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
85.99
85.99
1Y Return
41.93%
41.93%
Buy Reco %
82.35
82.35
PE Ratio
44.99
44.99
1Y Return
10.57%
10.57%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.40
6.40
1Y Return
57.42%
57.42%
Buy Reco %
100.00
100.00
KIMS Sentiment Analysis
KIMS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
KIMS Stock Summary · February 2026
In Q3 FY26, the company achieved record revenues of INR 1,003 crores, reflecting a modest year-on-year growth despite operational challenges from new units, which impacted profitability as evidenced by a significant decline in EBITDA margins. While the expansion into new markets, including a new hospital in Chennai, presents growth opportunities, the financial landscape remains complex with a net debt of INR 2,850 crores and ongoing efforts to stabilize operations. Management is optimistic about future growth, particularly in Telangana, where new facilities are expected to enhance capacity and revenue generation. However, challenges such as occupancy constraints and the need for effective doctor onboarding persist, necessitating a strategic focus on operational efficiency and cost management. Overall, the company is poised for growth, driven by innovative treatment technologies and a commitment to improving financial health amidst a dynamic healthcare market.
KIMS Stock Growth Drivers
KIMS Stock Growth Drivers
6Operational Achievements
KIMS Hospital has successfully completed significant operational milestones, including the establishment of 25 hospitals across
Financial Performance
In Q3 FY '26, KIMS reported a record-breaking revenue of over INR 1,000 crores, with
KIMS Stock Challenges
KIMS Stock Challenges
5Declining Profitability
KIMS Hospitals reported a significant decline in Profit After Tax (PAT), falling to INR 52
Operational Challenges and Cost Pressures
The company faced operational challenges, particularly with new units impacting EBITDA, which declined by 0.4%
KIMS Forecast
KIMS Forecasts
Price
Revenue
Earnings
KIMS Share Price Forecast
KIMS Share Price Forecast
2026
Current
₹675.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹675.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
KIMS Company Revenue Forecast
KIMS Company Revenue Forecast
2025
Current
₹3.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹3.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
KIMS Stock EPS (Earnings Per Share) Forecast
KIMS Stock EPS (Earnings Per Share) Forecast
2025
Current
₹9.61
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹9.61
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
KIMS
KIMS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
KIMS Income Statement
KIMS Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 655.36 | 609.09 | 637.60 | 693.00 | 782.30 | 790.20 | 812.20 | 878.70 | 964.90 | 1,002.90 | ||||||||||
Operating & Other expenses | 475.23 | 458.84 | 474.90 | 509.00 | 559.20 | 585.20 | 598.90 | 679.00 | 757.00 | 798.80 | ||||||||||
EBITDA | 180.13 | 150.25 | 162.70 | 184.00 | 223.10 | 205.00 | 213.30 | 199.70 | 207.90 | 204.10 | ||||||||||
| Depreciation/Amortization | 32.61 | 35.38 | 46.30 | 39.00 | 41.00 | 44.70 | 52.60 | 53.40 | 66.10 | 78.70 | ||||||||||
| PBIT | 147.52 | 114.87 | 116.40 | 145.00 | 182.10 | 160.30 | 160.70 | 146.30 | 141.80 | 125.40 | ||||||||||
| Interest & Other Items | 8.91 | 12.43 | 16.40 | 17.90 | 19.90 | 25.70 | 26.70 | 32.60 | 45.00 | 56.80 | ||||||||||
| PBT | 138.61 | 102.44 | 100.00 | 127.10 | 162.20 | 134.60 | 134.00 | 113.70 | 96.80 | 68.60 | ||||||||||
| Taxes & Other Items | 46.60 | 30.61 | 34.50 | 40.50 | 54.80 | 45.90 | 32.20 | 35.10 | 29.90 | 15.20 | ||||||||||
| Net Income | 92.01 | 71.83 | 65.50 | 86.60 | 107.40 | 88.70 | 101.80 | 78.60 | 66.90 | 53.40 | ||||||||||
| EPS | 2.30 | 1.80 | 1.64 | 2.16 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 |
KIMS Company Updates
FY 2026FY 2026
Investor Presentation
Feb 6PDF
Nov 11PDF
Nov 7PDF
Aug 6PDF
KIMS Stock Peers
KIMS Past Performance & Peer Comparison
KIMS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krishna Institute of Medical Sciences Ltd | 71.65 | 11.39 | — |
| Apollo Hospitals Enterprise Ltd | 77.60 | 10.11 | 0.16% |
| Max Healthcare Institute Ltd | 94.34 | 10.82 | 0.14% |
| Fortis Healthcare Ltd | 85.99 | 7.26 | 0.11% |
KIMS Stock Price Comparison
Compare KIMS with any stock or ETFCompare KIMS with any stock or ETF
KIMS
KIMS Holdings
KIMS Shareholdings
KIMS Promoter Holdings Trend
KIMS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
KIMS Institutional Holdings Trend
KIMS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
KIMS Shareholding Pattern
KIMS Shareholding Pattern
KIMS Shareholding History
KIMS Shareholding History
Foreign Institutions
Mutual Funds Invested in KIMS
Mutual Funds Invested in KIMS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Krishna Institute of Medical Sciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.3329% | Percentage of the fund’s portfolio invested in the stock 2.63% | Change in the portfolio weight of the stock over the last 3 months 0.30% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/82 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4704% | Percentage of the fund’s portfolio invested in the stock 1.82% | Change in the portfolio weight of the stock over the last 3 months -0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/88 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2629% | Percentage of the fund’s portfolio invested in the stock 2.40% | Change in the portfolio weight of the stock over the last 3 months -0.33% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/152 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing KIMS stock
smallcases containing KIMS stock
Looks like this stock is not in any smallcase yet.
KIMS Events
KIMS Events
KIMS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KIMS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
KIMS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KIMS has not given any dividends in last 5 years
KIMS Dividends
KIMS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeKIMS Stock News & Opinions
KIMS Stock News & Opinions
Articles & Videos
Corporate
Krishna Institute of Medical Sci. to convene board meeting
Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 11 March 2026.Powered by Capital Market - Live
4 days agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences consolidated net profit declines 39.80% in the December 2025 quarter
Net profit of Krishna Institute of Medical Sciences declined 39.80% to Rs 53.40 crore in the quarter ended December 2025 as against Rs 88.70 crore during the previous quarter ended December 2024. Sales rose 29.17% to Rs 997.70 crore in the quarter ended December 2025 as against Rs 772.40 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales997.70772.40 29 OPM %19.9424.24 - PBDT147.30179.30 -18 PBT68.60134.60 -49 NP53.4088.70 -40 Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences standalone net profit declines 5.23% in the December 2025 quarter
Net profit of Krishna Institute of Medical Sciences declined 5.23% to Rs 72.50 crore in the quarter ended December 2025 as against Rs 76.50 crore during the previous quarter ended December 2024. Sales rose 27.17% to Rs 441.90 crore in the quarter ended December 2025 as against Rs 347.50 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales441.90347.50 27 OPM %28.9029.61 - PBDT120.40116.80 3 PBT97.80101.90 -4 NP72.5076.50 -5 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Krishna Institute of Medical Sci. to convene board meeting
Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences consolidated net profit declines 37.71% in the September 2025 quarter
Net profit of Krishna Institute of Medical Sciences declined 37.71% to Rs 66.90 crore in the quarter ended September 2025 as against Rs 107.40 crore during the previous quarter ended September 2024. Sales rose 23.59% to Rs 960.70 crore in the quarter ended September 2025 as against Rs 777.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales960.70777.30 24 OPM %21.2328.06 - PBDT163.20203.20 -20 PBT97.10162.20 -40 NP66.90107.40 -38 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Krishna Institute of Medical Sci. to table results
Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
KIMS commences operations of new hospital at Mahadevapura, Bengaluru
KIMS Hospital Bengaluru, a wholly owned subsidiary of Krishna Institute of Medical Science, has formally commenced operations at its newly established hospital located in Mahadevapura, Bengaluru. The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital, designed to provide comprehensive medical services across a wide range of specialties. The hospital is equipped with over 35 medical and surgical specialties, 120+ advanced ICU beds, and more than 100 dedicated OPD (Outpatient Department) beds, catering to both critical and routine healthcare needs. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Krishna Institute of Medical Sciences consolidated net profit declines 9.24% in the June 2025 quarter
Net profit of Krishna Institute of Medical Sciences declined 9.24% to Rs 78.60 crore in the quarter ended June 2025 as against Rs 86.60 crore during the previous quarter ended June 2024. Sales rose 26.61% to Rs 871.60 crore in the quarter ended June 2025 as against Rs 688.40 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales871.60688.40 27 OPM %22.1026.06 - PBDT167.10166.10 1 PBT113.70127.10 -11 NP78.6086.60 -9 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Krishna Institute of Medical Sci. to announce Quarterly Result
Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 6 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Krishna Institute of Medical Sci. AGM scheduled
Krishna Institute of Medical Sci. announced that the 23th Annual General Meeting(AGM) of the company will be held on 29 August 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 22.22%, vs industry avg of 13.46%
Over the last 5 years, market share increased from 2.71% to 3.74%
Over the last 5 years, net income has grown at a yearly rate of 26.4%, vs industry avg of 42.5%